AIDS Articles A-Z
Early symptoms of HIV typically either do not appear at all or consist of a flu-like illness. This portion of the eMedTV archives describes possible early symptoms of HIV as they progress, including frequent fever, fatigue, skin rashes, and others.
Emtriva is a prescription medicine that is used in the treatment of HIV and AIDS. This eMedTV article offers an overview of Emtriva, including information on how it works, possible side effects, tips on when and how to take the medication, and more.
This eMedTV page explains that although it is not known if Emtriva passes through breast milk, it is generally recommended that women with HIV or AIDS avoid breastfeeding. This page further discusses taking Emtriva and breastfeeding at the same time.
There are several possible side effects of Emtriva, and depression appears to be one of them. This eMedTV page discusses the results of clinical trials on Emtriva and depression, and explains why depression may be caused by other factors.
Emtriva is generally considered safe for women to take when pregnant. This eMedTV article provides information on Emtriva and pregnancy, including an explanation of why the FDA classifies it as a pregnancy Category B medication.
This eMedTV segment highlights some of the factors that can affect your Emtriva dosage and offers tips on when and how to take the medication. Typical doses for adults, children, and people with kidney disease are also provided.
Emtriva can interact with drugs such as valganciclovir, ribavirin, and ganciclovir. This portion of the eMedTV library explains these and other Emtriva drug interactions in detail, including information on the side effects that may occur as a result.
This eMedTV segment explains that possible signs of an Emtriva overdose can include unusual bruising or bleeding, trouble breathing, and an irregular heartbeat. This page also describes treatment options that are available for an Emtriva overdose.
Common side effects of Emtriva can include headaches, dizziness, and nausea. This portion of the eMedTV library outlines other common Emtriva side effects that can occur, as well as the side effects that may require immediate medical attention.
Emtriva is used for the treatment of HIV and AIDS in adults and children. This selection from the eMedTV Web site explains how the medication works to prevent the HIV virus from multiplying and also describes possible off-label Emtriva uses.
Emtriva Warnings and Precautions
Emtriva can decrease the ability of bone marrow to produce blood cells. This eMedTV article provides several other Emtriva warnings and precautions, including what to tell your doctor before taking the drug, as well as who should not take Emtriva.
Epoetin alfa is a medicine that is used to treat anemia due to chemotherapy, renal failure, or zidovudine. This eMedTV page explains how epoetin alfa works and offers more details on the drug's effects, dosing information, and possible side effects.
The usual epoetin alfa dose for anemia due to kidney failure is 50 to 100 units per kg three times a week. This eMedTV Web page also provides epoetin alfa dosing guidelines for the treatment of anemia due to chemotherapy and zidovudine (an HIV drug).
Epzicom is a medication that is available by prescription to treat HIV and AIDS. This page on the eMedTV site describes Epzicom in more detail and offers an in-depth look at the drug's effects, dosing guidelines, potential side effects, and more.
It is generally recommended to avoid breastfeeding while taking Epzicom. This eMedTV Web page offers more information on Epzicom and breastfeeding, and discusses the dangers of breastfeeding if you have HIV or AIDS.
Depression appears to be a possible side effect of Epzicom. This section of the eMedTV Web site contains more detailed information about Epzicom and depression, and explains how many people developed depression during clinical trials.
Epzicom may not be safe for use during pregnancy. This portion of the eMedTV site provides more information on Epzicom and pregnancy, and describes the problems that occurred when individual components of the drug were given to pregnant animals.
There is only one recommended Epzicom dosage for the treatment of HIV or AIDS -- one tablet once daily. This eMedTV article provides other important Epzicom dosing information and offers a list of tips for when and how to take the medicine.
Alcohol, interferon medications, and ribavirin may potentially cause Epzicom drug interactions. This eMedTV resource lists other medicines that may interact with Epzicom and describes the possible effects of these negative interactions.
An Epzicom overdose may potentially lead to bone marrow suppression. This eMedTV segment describes other possible effects of an Epzicom overdose and lists various treatment options that are currently available.
Common Epzicom side effects may include dizziness, abdominal pain, and insomnia. This part of the eMedTV library lists other side effects that may occur with Epzicom, including potentially serious side effects that should be reported to a doctor.
Epzicom is used for the treatment of HIV or AIDS. This article from the eMedTV archives explains whether the drug can be used in children, describes how the medication works, and discusses possible off-label Epzicom uses.
Epzicom Warnings and Precautions
Before using Epzicom, tell your doctor if you have anemia, kidney disease, or liver disease. This eMedTV page offers more Epzicom warnings and precautions, including possible side effects that may occur and information on who should not take the drug.
Fuzeon is prescribed in combination with other drugs to treat HIV and AIDS. This eMedTV article provides detailed information on Fuzeon, including potential side effects, dosing information, and important tips and precautions when taking the drug.
Taking Fuzeon and breastfeeding is typically not a safe combination. This selection from the eMedTV Web site explains why women who have HIV or AIDS should generally not breastfeed in order to prevent transmitting the HIV virus to their infant.
It is generally considered safe to take Fuzeon during pregnancy. This article from the eMedTV Web site explains the results of animal studies involving Fuzeon and pregnancy, and describes why the FDA classifies Fuzeon as a pregnancy Category B drug.
This eMedTV page explains that the recommended Fuzeon dosage when treating HIV or AIDS will depend on several factors, such as age and weight. This page also lists Fuzeon dosing guidelines for adults and children, and offers tips for taking the drug.
At this time, there are no known Fuzeon drug interactions. However, as this eMedTV resource explains, this does not mean that there is no possibility that Fuzeon may interact with other medicines, as it has not been tested with every single drug.
This eMedTV Web page discusses Fuzeon, a medication for treating HIV and AIDS. Information includes dosing, side effects, interactions, warnings, and side effects.
This portion of the eMedTV archives describes what to expect if you take too much Fuzeon. This resource also covers the factors that may affect a Fuzeon overdose and describes possible treatment options (such as supportive care).
Some of the most commonly reported Fuzeon side effects include reactions at the injection site. This eMedTV Web page outlines other possible side effects of the drug, including more serious side effects that may require prompt medical attention.
Fuzeon is used for the treatment of HIV infection and AIDS. This portion of the eMedTV archives explains how the medication works to prevent the HIV virus from entering the cells and multiplying. This page also discusses Fuzeon uses in children.
Fuzeon Warnings and Precautions
This portion of the eMedTV archives takes an in-depth look at several Fuzeon warnings and precautions, such as the possibility of the medication causing pneumonia or allergic reactions. This article also describes who should not take the drug.
Patents currently prevent any generic Agenerase from being made in the United States until 2013. This eMedTV resource discusses factors that may extend that date beyond 2013. This page also warns people against so-called generic Agenerase products.
Aptivus is not available in generic form at this time. As this eMedTV resource explains, while the drug is currently under the protection of a patent, companies can begin making generic Aptivus products as soon as this patent expires in May 2014.
Currently, no generic Atripla products are licensed for sale. As this eMedTV page explains, the earliest possible date that generic Atripla could become available is July 2017, when the patents for the three active ingredients in the drug expire.
Generic Combivir will not be available until May 2010, at the earliest. This eMedTV page explains why, advises against buying any alleged generic versions of the drug, and describes the difference between generic names of drugs and generic versions.
At this time, there are no generic versions of Crixivan licensed for sale. This part of the eMedTV library further explains when generic Crixivan products may become available and describes the difference between a generic drug and its "generic name."
Generic Emtriva is not available at this time. This portion of the eMedTV archives explains why generic Emtriva is not currently manufactured in the United States and discusses when a generic version of the drug may become available.
Epzicom is currently not available in generic form. This page from the eMedTV library further discusses when generic Epzicom may become available and explains whether abacavir/lamivudine is a generic version of Epzicom.
Patents currently prevent any generic Fuzeon from being manufactured in the United States. This eMedTV page explains that the earliest possible date a generic form of the drug could become available is in June 2013, when the first patent expires.
As this portion of the eMedTV library explains, Hivid is protected by a patent that prevents any generic version of the drug from being manufactured. The earliest date that a generic Hivid could become available is July 2008, when the patent expires.
Patents currently prevent any generic Invirase from being made in the United States. This eMedTV page explains that a generic version could become available in 2010, when the patent expires, and also explains why saquinavir is not a generic Invirase.
October 2022 is the earliest possible date that generic Isentress could become available. This portion of the eMedTV Web site explains that patents currently prevent a generic version from being manufactured in the United States.
December 2015 is most likely the earliest possible date that generic Kaletra could be available. This eMedTV article explains the potential dangers of buying so-called generic Kaletra products before an approved version is actually available.
Generic Lexiva products will not be available until December 2017 at the earliest. This eMedTV Web page lists possible factors that may extend the exclusivity period of Lexiva beyond 2017 and explains the risks of buying "generic" Lexiva today.
Norvir is not available in generic form at this time. This eMedTV article further discusses when generic Norvir products may be available and explains why it may be dangerous to buy a generic form of the drug before an approved version is available.
There are currently no generic Prezista products licensed for sale. This article from the eMedTV library discusses when a generic version may be available and explains the difference between a generic drug and its "generic name."
Rescriptor is not yet available in generic form. The drug, as this eMedTV page explains, is currently protected by a patent that prevents any generic versions from being made. When the patent expires in 2013, generic Rescriptor may be available.
Generic Retrovir products are available in various forms, including capsules, tablets, and syrup. This eMedTV article lists the strengths available for generic Retrovir drugs and explains whether these products are equivalent to brand-name Retrovir.
Reyataz will not be available in generic form until April 2017 at the earliest. This part of the eMedTV archives discusses when a generic version may be available and explains why it may be dangerous to buy so-called "generic Reyataz" products.
Patents currently prevent any generic Selzentry from being manufactured in the United States. This eMedTV page explains that 2019 is the earliest date that a generic version may become available and explains why maraviroc is not a generic version.
There are currently no generic versions of Sustiva licensed for sale. This page from the eMedTV archives explains when generic Sustiva products may become available and discusses the possible dangers of buying so-called generic medications.
December 2009 is the earliest possible date that generic Trizivir could become available. As this eMedTV page explains, Trizivir is currently being protected by a patent that prevents any generic Trizivir products from being manufactured in the U.S.
Truvada is currently under the protection of patents that prevent any generic versions from being made. As this eMedTV page explains, other companies are expected to begin making generic Truvada products as soon as the patents expire in July 2017.
As this eMedTV segment explains, generic Videx is available in the form of delayed-release capsules and as an oral solution. This page also explains that the FDA has determined that generic Videx is equivalent to the brand-name medication.
Viracept is currently not available in generic form. This part of the eMedTV library explains when generic Viracept products may become available and discusses the dangers of buying so-called "generic" versions of the drug before the patent expires.
Viramune is not yet available in generic form. As this section of the eMedTV Web site explains, it is expected that several drug companies will begin manufacturing generic Viramune products as soon as the medication's patent expires in May 2012.
There are currently no generic Viread products available on the market. As this eMedTV page explains, unless circumstances arise to extend the exclusivity period of Viread beyond July 2017, companies will begin making generic versions at that time.
Currently, Zerit is not available in generic form because it is protected by a patent. This eMedTV page explains when generic Zerit may become available and covers the dangers of buying so-called "generic Zerit" before an approved form is available.
Patents currently prevent any generic Ziagen from being made in the United States. This eMedTV page explains that 2009 is the earliest date that a generic Ziagen could become available. This page also warns people about fake generic Ziagen products.
Hepatitis C and HIV can both be transmitted through contaminated needles or unprotected sex. As this eMedTV Web page explains, a co-infection with hepatitis C and HIV can be quite serious and can affect the treatment for either of the conditions.
HIV (human immunodeficiency virus) gradually makes the body unable to fight certain cancers and infections. This eMedTV Web page discusses the diagnosis, prevention, transmission, and symptoms of HIV and AIDS.
Treatment options for HIV and depression include medications, therapy, and herbal remedies. This page of the eMedTV library discusses HIV and depression, and explains the importance of recognizing and treating it in people with serious illnesses.